[AACR] SAM Competitive PRMT5 Inhibitor PF-06939999 Demonstrates Antitumor Activity in Splicing Dysregulated NSCLC with Decreased Liability of Drug Resistance

uyuy Post time 2021-12-13 12:19:51 | Show all posts |Read mode
Reward10points

journal£ºMolecular Cancer Therapeutics

Authors£ºKristen Jensen-Pergakes; John Tatlock; Karen A Maegley; Indrawan J. McAlpine; Michele A McTigue; Tao Xie; Christopher P Dillon; Yuli Wang; Shinji Yamazaki; Noah Spiegel; Manli Shi; Amy Nemeth; Natalie Miller; Eleanore Hendrickson; Hieu Lam; John Sherrill; Chi-Yeh Chung; Elizabeth A McMillan; Shannon Karlicek Bryant; Prakash Palde; John Braganza; Alexei Brooun; Ya-Li Deng; Vesta Goshtasbi; Susan E Kephart; Robert A. Kumpf; Wei Liu; Ryan L Patman; Eugene Rui; Stephanie Scales; Michelle Tran-Dube; Fen Wang; Martin Wythes; Thomas A. Paul

Published date£º--

DOI£º10.1158/1535-7163.mct-21-0620

Article link£ºhttp://dx.doi.org/10.1158/1535-7163.mct-21-0620

Article Source£ºAmerican Association for Cancer Research (AACR)¡£


Remark£º

Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply2 Show all posts
GD4E1 Post time 2021-12-13 12:19:52 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

uyuy Post time 2021-12-14 13:14:28 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    130

Latest Reply

Return to the list